购物车
- 全部删除
您的购物车当前为空
Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805)
还可以产品编号 TMAY-01691
别名 VEGFR2, VEGFR 2, VEGFR, FLK1, CD309
Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) 是一种 Rabbit 抗体，靶向 Phospho-VEGF Receptor 2 (Tyr1175)。Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) 可用于 WB。
Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805)
Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805)
还可以产品编号 TMAY-01691 别名 VEGFR2, VEGFR 2, VEGFR, FLK1, CD309
Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) 是一种 Rabbit 抗体，靶向 Phospho-VEGF Receptor 2 (Tyr1175)。Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) 可用于 WB。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 20 μL | ¥ 689 | 5日内发货 | |
| 100 μL | ¥ 1,984 | 5日内发货 |
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) is a Rabbit antibody targeting Phospho-VEGF Receptor 2 (Tyr1175). Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) can be used in WB. |
| 别名 | VEGFR2, VEGFR 2, VEGFR, FLK1, CD309 |
| Ig Type | Monoclonal Rabbit IgG |
| 克隆号 | 7E805 |
| 交叉反应 | Human;
Predicted to React with:Species predicted to react based on 100% sequence homology: Cynomolgus, Pig |
| 验证活性 | 1. Western blot analysis of extracts from serum-starved HUVEC, untreated(line A) or treated with VEGF (50ng/mL, 2min; +)(line B), using Phospho-VEGF Receptor 2 (Tyr1175) rabbit monoclonal Antibody at 1:10000 dilution (upper) or Anti-Actin Antibody, Chimeric Rabbit Monoclonal at 1:50000 dilution (lower). 2. Western blot analysis of extracts from serum-starved HUVEC, untreated (line A); treated with VEGF (50ng/mL, 2min; +) (line B); treated with VEGF and λ-phosphatase (line C) using Phospho-VEGF Receptor 2 (Tyr1175) rabbit monoclonal Antibody at 1:10000 dilution. (Validation Experiment) 3. Western blot analysis of extracts from serum-starved HUVEC, untreated (line A); treated with VEGF (50ng/mL, 2min), without peptide (line B) or antigen-specific phosphopeptide (line C) or antigen-specific peptide (line D) using Phospho-VEGF Receptor 2 (Tyr1175) rabbit monoclonal Antibody at 1:10000 dilution. (Validation Experiment) |
| 应用 | WB |
| 推荐剂量 | WB: 1:1000-1:10000 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Rabbit |
| 构建方式 | This antibody was obtained from a rabbit immunized with a synthetic peptide corresponding to the residues around Tyr1175 of Human Phospho-VEGF Receptor 2. |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | 10 mM sodium HEPES, 150 mM NaCl, 100 μg/mL BSA, 50% glycerol, pH 7.5 |
| 研究背景 | VEGFR2 also called KDR or Flk-1, is identified as the receptor for VEGF and VEGFC and an early marker for endothelial cell progenitors, whose expression is restricted to endothelial cells in vivo. VEGFR2 was shown to be the primary signal transducer for angiogenesis and the development of pathological conditions such as cancer and diabetic retinopathy. It has been shown that VEGFR2 is expressed mainly in the endothelial cells, and the expression is upregulated in the tumor vasculature. Thus the inhibition of VEGFR2 activity and its downstream signaling are important targets for the treatment of diseases involving angiogenesis. VEGFR2 transduces the major signals for angiogenesis via its strong tyrosine kinase activity. However, unlike other representative tyrosine kinase receptors, VEGFR2 does not use the Ras pathway as major downstream signaling but rather uses the phospholipase C-protein kinase C pathway to signal mitogen-activated protein (MAP)-kinase activation and DNA synthesis. VEGFR2 is a direct and major signal transducer for pathological angiogenesis, including cancer and diabetic retinopathy, in cooperation with many other signaling partners; thus, VEGFR2 and its downstream signaling appear to be critical targets for the suppression of these diseases. VEGF and VEGFR2-mediated survival signaling are critical to endothelial cell survival, maintenance of the vasculature and alveolar structure, and regeneration of lung tissue. Reduced VEGF and VEGFR2 expression in emphysematous lungs has been linked to increased endothelial cell death and vascular regression.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| 偶联 | Unconjugated |
| 免疫原 | A synthetic peptide corresponding to the residues around Tyr1175 of Human Phospho-VEGF Receptor 2 |
| 抗原种属 | Human |
| 研究领域 | Cancer Drug Targets, Hemangioblast Markers, Receptor Tyrosine Kinases (RTKs) |
存储&运输
| 储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| 运输方式 | Shipping with blue ice. |
SCI 文献
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
评论列表
预览
Related Tags: buy Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) | purchase Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) | Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805) cost | order Anti-Phospho-VEGF Receptor 2 (Tyr1175) Antibody (7E805)
嗨！有任何问题？点我咨询
评论内容